Immune-Mediated Liver Diseases
The Stanford Immune-Mediated liver diseases programs offers comprehensive care for patients with autoimmune liver diseases. Our team of physicians have expertise in the diagnosis and management of these complex medical conditions.
CONDITIONS
We treat the following conditions:
- Autoimmune Hepatitis
- Primary biliary cholangitis
- Primary sclerosing cholangitis
- IgG4 related cholangitis
- Other autoimmune liver diseases
CLINICAL TRIALS
We have extensive experience in selecting the right patients for the right trials.
OUR TEAM
We have a team of dedicated hepatologists and support staff with extensive expertise in taking care of patients with immune-mediated liver diseases.
PATIENT EDUCATION
Some resources for further information on immune-mediated liver diseases:
- National Institute of Health (NIH)- Autoimmune Hepatitis
- PSC Partners- Primary Sclerosing cholangitis
- WebMD- Autoimmune Hepatitis
- American Liver Foundation- Autoimmune Hepatitis
- National Organization for Rare Disorders (NORD)- Primary biliary cholangitis